Non-genetic factors and polymorphisms in genes CYP2C9 and VKORC1: predictive algorithms for TTR in Brazilian patients on warfarin

被引:0
|
作者
Marcus Fernando S. Praxedes
Maria Auxiliadora P. Martins
Aline O. M. Mourão
Karina B. Gomes
Edna A. Reis
Renan P. Souza
Emílio Itamar F. Campos
Daniel D. Ribeiro
Manoel Otávio C. Rocha
机构
[1] Universidade Federal de Minas Gerais,Faculdade de Farmácia
[2] Universidade Federal do Recôncavo da Bahia,Centro de Ciências da Saúde
[3] Universidade Federal de Minas Gerais,Faculdade de Medicina
[4] Universidade Federal de Minas Gerais,Hospital das Clínicas
[5] Universidade Federal de Minas Gerais,Instituto de Ciências Biológicas
关键词
Algorithms; Warfarin; Cytochrome P-450 ; protein; Quality of health care;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:199 / 209
页数:10
相关论文
共 50 条
  • [21] Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population
    Mahvash Farajzadeh-Dehkordi
    Fatemeh Samiee-Rad
    Seyed Saeed Farzam
    Amir Javadi
    Sara Cheraghi
    Dariush Hamedi-Asl
    Babak Rahmani
    Pharmacological Reports, 2023, 75 : 695 - 704
  • [22] Dependency of phenprocoumon dosage on polymorphisms in the VKORC1 and CYP2C9 genes
    Qazim, Berisha
    Stoellberger, Claudia
    Krugluger, Walter
    Dossenbach-Glaninger, Astrid
    Finsterer, Josef
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 28 (02) : 211 - 214
  • [23] Dependency of phenprocoumon dosage on polymorphisms in the VKORC1 and CYP2C9 genes
    Berisha Qazim
    Claudia Stöllberger
    Walter Krugluger
    Astrid Dossenbach-Glaninger
    Josef Finsterer
    Journal of Thrombosis and Thrombolysis, 2009, 28 : 211 - 214
  • [24] Prevalence of combinatorial genetic polymorphisms of CYP2C9 and VKORC1 in acute stroke patients: implications for warfarin management
    Supe, S.
    Poljakovic, Z.
    Bozina, N.
    Matijevic, V.
    Bazina, A.
    Miismas, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 167 - 167
  • [25] VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance
    Azzam, Hanan
    Elwakeel, Hossam
    Awad, Ibrahim
    El-Farahaty, Reham
    El-Gilany, Abdel-Hady
    El-Sharawy, Solafa
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (02) : 121 - 126
  • [26] Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin
    Barros Melo da Silveira, Maria Mariana
    Melo, Leiliandry de Ara
    Ferreira Gomes, Filipe Maia
    Barreto da Rocha Andrade, Leonardo Jose de Cupertino
    Serur, Isabela Paulino
    de Vasconcellos Piscoya, Isabelle Cecilia
    Gueiros, Raposo Marina
    do O, Kleyton Palmeira
    de Lima, Raul Emidio
    Eulalio Brasileiro, Victor Arthur
    Silva Vasconcelos, Luydson Richardson
    Sobral Filho, Dario Celestino
    APPLICATION OF CLINICAL GENETICS, 2019, 12 : 151 - 159
  • [27] Algorithm for predicting low maintenance doses of warfarin using age and polymorphisms in genes CYP2C9 and VKORC1 in Brazilian subjects
    Magalhaes Mourao, Aline de Oliveira
    Braga Gomes, Karina
    Afonso Reis, Edna
    Pedra de Souza, Renan
    de Freitas Campos, Emilio Itamar
    Dias Ribeiro, Daniel
    da Costa Rocha, Manoel Otavio
    Parreiras Martins, Maria Auxiliadora
    PHARMACOGENOMICS JOURNAL, 2020, 20 (01): : 104 - 113
  • [28] Algorithm for predicting low maintenance doses of warfarin using age and polymorphisms in genes CYP2C9 and VKORC1 in Brazilian subjects
    Aline de Oliveira Magalhães Mourão
    Karina Braga Gomes
    Edna Afonso Reis
    Renan Pedra de Souza
    Emílio Itamar de Freitas Campos
    Daniel Dias Ribeiro
    Manoel Otávio da Costa Rocha
    Maria Auxiliadora Parreiras Martins
    The Pharmacogenomics Journal, 2020, 20 : 104 - 113
  • [29] Effect of Genetic Variants, Especially CYP2C9 and VKORC1, on the Pharmacology of Warfarin
    Fung, Erik
    Patsopoulos, Nikolaos A.
    Belknap, Steven M.
    O'Rourke, Daniel J.
    Robb, John F.
    Anderson, Jeffrey L.
    Shworak, Nicholas W.
    Moore, Jason H.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2012, 38 (08): : 893 - 904
  • [30] Effect of CYP2C9 and VKORC1 genetic polymorphism on Warfarin dose requirement
    Ashavaid, T. F.
    Ponde, C. K.
    Raghavan, R.
    Kapadia, F. N.
    Shah, S. A.
    Natarajan, S.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 507 - 508